Variant · Snv
GAA NM_000152.5(GAA):c.-32-13T>G
CI-VAR-00005393Explore in graph →NM_000152.5:c.-32-13T>GClinVar 4027 rs386834236
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 4027 | Pathogenic | reviewed by expert panel | 3 | Glycogen storage disease, type II; Myopathy; Glycogen storage disease due to acid maltase deficiency, late-onset; Glycogen storage disease, type IV; Cardiovascular phenotype; GAA-related disorder; Glycogen storage disease; Thymoma; Malignant tumor of esophagus; Cervical cancer; Sarcoma; Uterine corpus endometrial carcinoma; Ovarian serous cystadenocarcinoma; Fetal anomalies with a likely genetic cause; GAA-related disorders | germline | 66 | Oct 01, 2024 | clinvar |